In previous studies, the overexpression of PRC1 mediated the early recurrence of hepatocellular carcinoma through the Wnt/β-catenin signaling pathway and increased the resistance of HCC to paclitaxel (38, 39). The gene discussed is PRC1; the disease is hepatocellular carcinoma.